Effect of thickening agents, based on soluble dietary fiber, on the availability of calcium, iron, and zinc from infant formulas.

Department of Pharmaceutical Sciences, Laboratory of Food Sciences, University of Antwerp, Antwerp (Wilrijk), Belgium.
Nutrition (Impact Factor: 2.86). 01/2001; 17(7-8):614-8. DOI: 10.1016/S0899-9007(01)00541-X
Source: PubMed

ABSTRACT Although it is accepted that dietary fiber probably is not needed in the diets of infants younger than 1 y, babies suffering from regurgitation are often fed with infant formulas thickened with considerable amounts of fiber. The effect of increasing amounts of alginic acid, locust-bean gum, and guar gum was studied from casein and whey-based infant formulas. A dialysis in vitro method with preliminary intraluminal digestion, adapted to the conditions of infants younger than 6 mo, was used. Human milk was used as the reference standard. Elemental contents of samples and dialysates were determined by atomic absorption spectrometry. Soluble dietary fiber inhibited mineral availability more in casein than in whey-based formulas. Mineral availabilities from casein- and whey-based formulas supplemented with 0.42 g of locust-bean gum/100 mL were 9.4% (0.7) and 10.4% (0.6) for calcium (P < 0.05), 0.32% (0.08) and 1.45% (0.17) for iron (P < 0.05), and 3.2% (0.2) and 5.6% (0.5) for zinc (P < 0.05), respectively. Calcium availability from the whey formula decreased in the presence of each fiber source, especially guar gum and alginic acid. Supplementing 2 g of alginic acid-based agents per 100 mL depressed calcium availability from 13.3% (1.2) to 5.3% (0.3; P < 0.05). With respect to iron and zinc, availabilities increased from 1.28% (0.28) to 6.05% (0.96; P < 0.05) and from 6.7% (0.6) to 10.2% (1.0), respectively, with the addition of 2 g of alginic acid (P < 0.05). Both gums lowered iron and zinc availabilities, and guar gum affected iron availability more severely than locust-bean gum did. Iron availabilities were 1.45% (0.17) from formula thickened with locust-bean gum (0.42 g/100 mL) and 0.92% (0.15) from formula thickened with guar gum (P < 0.05). Adding thickening agents based on soluble dietary fiber to traditional infant formulas probably affects calcium, iron, and zinc availability in various ways.

  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Gastroesophageal reflux (GER) is common in infants during the early months of life, as a result of a weak development of the regulatory mechanisms. Nevertheless, GER tends to disappear as infants grow. Nowadays, GER has become a common cause ofpediatric consultation in the clinical practice, especially if it is followed by vomits. Sometimes, changing baby position while feeding seems to be a solution to reduce symptoms, while other times it is necessary manage the problem according to clinical practice guidelines. In these guidelines, the use of anti-regurgitation infant formulas are included, which has been formulated with thickening agents and/or whey/casein ratio modification. Antiregurgitation milk products are available without pediatric prescription in chemists and other authorized establishments. Published studies on antiregurgitant infant formulas show some contradictory conclusions about their use. A negative effect on mineral and micronutrient bioavailability has been proposed by some authors, in relation to the presence of thickening agents used as ingredients. Different aspects which require more research, related to the use of antiregurgitation infant formulas, have been included in this review with the aim ofproducing more effective and safety products for an especially vulnerable population, where an optimum feeding will lead to an adequate development and good health status in the future.
    Revista Chilena de Nutricion 12/2011; 38(4):481-490.
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Calcium, phytic acid, polyphenols and fiber are major inhibitors of iron absorption and they could be found in excess in some diets, thereby altering or modifying the iron nutrition status. The purpose of this study is to evaluate the effect of calcium, tannic acid, phytic acid, and pectin over iron uptake, using an in vitro model of epithelial cells (Caco-2 cell line). Caco-2 cells were incubated with iron (10-30 μM) with or without CaCl2 (500 and 1,000 μM) for 24 h. Then, cells were challenged with phytic acid (50-150 μM); pectin (50-150 nM) or tannic acid (100-500 μM) for another 24 h. Finally, (55)Fe (10 μM) uptake was determined. Iron dialyzability was studied using an in vitro digestion method. Iron uptake in cells pre-incubated with 20 and 30 μM Fe was inhibited by CaCl2 (500 μM). Iron uptake decreased in cells cultured with tannic acid (300 μM) and CaCl2 (500-1,000 μM) (two-way ANOVA, p = 0.002). Phytic acid also decreased iron uptake mainly when cells were treated with CaCl2 (1,000 μM) (two-way ANOVA; p < 0.05). Pectin slightly decreased iron uptake (p = NS). Iron dialyzability decreased when iron was mixed with CaCl2 and phytic or tannic acid (T test p < 0.0001, for both) but not when mixed with pectin. Phytic acid combined with calcium is a strong iron uptake inhibitor. Pectin slightly decreased iron uptake with or without calcium. Tannic acid showed an unexpected behavior, inducing an increase on iron uptake, despite its low Fe dialyzability.
    Biological trace element research 02/2014; · 1.92 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Locust bean gum (LBG) is a galactomannan polysaccharide used as thickener in infant formulas with the therapeutic aim to treat uncomplicated gastroesophageal reflux (GER). Since its use in young infants below 12 weeks of age is not explicitly covered by the current scientific concept of the derivation of health based guidance values, the present integrated safety review aimed to compile all the relevant preclinical toxicological studies and to combine them with substantial evidence gathered from the clinical paediatric use as part of the weight of evidence supporting the safety in young infants below 12 weeks of age. LBG was demonstrated to have very low toxicity in preclinical studies mainly resulting from its indigestible nature leading to negligible systemic bioavailability and only possibly influencing tolerance. A standard therapeutic level of 0.5 g/100 mL in thickened infant formula is shown to confer a sufficiently protective Margin of Safety. LBG was not associated with any adverse toxic or nutritional effects in healthy term infants, while there are limited case-reports of possible adverse effects in preterms receiving the thickener inappropriately. Altogether, it can be concluded that LBG is safe for its intended therapeutic use in term-born infants to treat uncomplicated regurgitation from birth onwards.
    Regulatory toxicology and pharmacology : RTP. 07/2014;

Full-text (3 Sources)

Available from
Nov 4, 2014